Navigation Links
Tenaxis Medical Inc. Announces First Human Use of Vascular Sealant

Tenaxis Medical, Inc., a medical device company founded in 2004 to bring high performance surgical sealants to the vascular and general surgical markets, announced that vascular surgeons at the Krankenhaus Friedrichstadt in Dresden, Germany were the first to clinically use their novel high performance vascular sealant, ArterX(TM).

The investigational product was used on a 74 year old man suffering from vascular insufficiency of the leg requiring the implant of a synthetic vascular bypass graft. This is a procedure that is usually accompanied by profuse bleeding at the suture lines and requires the physician to use manual pressure for up to 30 minutes to stop the bleeding. The sealant, which has been designed to cure in 15 seconds, was applied over the top of the suture line and immediately stopped the bleeding through the needle holes created when the artificial graft was sutured in place and the artery-graft junction was exposed to full arterial pressure.

Dr James Zimmerman, a vascular surgeon with Pacific Coast Cardiac & Vascular Surgeons, Redwood City, California, attended the first surgery and said "the procedure went flawlessly, the product was deployed over the top of the sutures, and on clamp release there was absolutely no bleeding." This is the first of up to 60 procedures that are anticipated to be conducted in Germany. Procedures are also underway in hospitals in Ulm and Cologne and the study is expected to be fully enrolled by the end of the summer.

The ArterX Vascular Sealant was developed by Tenaxis Medical's team in Mountain View, CA and is based upon a proprietary technology that uses a powerful crosslinking agent that covalently binds to proteins in both the sealant and human tissue. "I am extremely proud of the progress the team has achieved in developing a meaningful new generation of vascular sealants," said Ronald Dieck, President and CEO of Tenaxis Medical, Inc. "This is the first step in a comprehens ive clinical program to position this product for regulatory clearance and subsequent launch in Europe in early 2008, and in the USA in early 2009.


'"/>




Related medicine news :

1. Indian Nationals with Foreign Medical Degrees can now practice in India
2. Meditation Works Medically
3. Sleep Disorders Could Indicate Other Medical Problems
4. Being Obese Increases Ones Risk Of A wrong Diagnosis During Medical Imaging
5. Hypnosis Found To Reduce Stress In Children During Medical Procedures
6. Stanford Medical Center Implements The First Virtual Cardiac Ultrasound
7. Ayurvedic Therapies Cashing In On Medical Tourism
8. Prevention And Timely Medical Care Can Help With Bug Bites
9. Government Organisation Proposes Strict Guidelines For SubStandard Medical Devices
10. Grant of $7 million for Orissa Medical College from Japan
11. Indian Hospitals – A Destination For Quality Medical Care
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The ... the most popular and least understood books in the Holy Scriptures, Revelation. The Book ... have baffled scholars for centuries. Many have tossed it off as mere rubbish, but ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the ... danger possible to save lost souls in the Philippines. “The Journey: From the Mountains ... a dedicated teacher of the Bible. She has taught all ages and currently teaches ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San ... using cutting-edge Oventus O2Vent technology. As many as 18 million Americans are ... cessation in breathing. Oral appliances can offer significant relief to about 75 percent ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ... introduction of an innovative new design of the shoulder pad. The shoulder pad ... comfort while controlling your pain while using cold therapy. By utilizing ice and water ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: , ... to enable prevention of a major side effect of chemotherapy in children. Cisplatin ... patients. For cisplatin, hearing loss is FDA listed on-label as a dose limiting ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... Pa. , Oct. 12, 2017 ... leader in innovative solutions for injectable drug administration, today ... before the market opens on Thursday, October 26, 2017, ... the results and business expectations at 9:00 a.m. Eastern ... (U.S.) or 253-336-8738 (International). The conference ID is 94093362. ...
(Date:10/11/2017)... 2017  Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: HRC), today ... Las Piedras, Puerto Rico , where ... Following a comprehensive ... minor structural damage, temporary loss of power and minimal ... completed, manufacturing operations have resumed, and the company expects ...
(Date:10/5/2017)...  In response to the nationwide opioid epidemic, ... (AAOMS) released prescribing recommendations that urge ibuprofen – ... a first-line therapy to manage a patient,s acute ... Recognizing the value and importance of the ... Acute and Postoperative Pain Management" stresses that practitioners ...
Breaking Medicine Technology: